Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.87 USD | -1.54% |
|
-1.55% | -42.45% |
05-15 | PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-10 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.45% | 107M | |
+17.74% | 125B | |
+13.30% | 108B | |
-6.88% | 24.21B | |
+0.29% | 22.78B | |
-11.02% | 17.96B | |
-41.74% | 16.43B | |
-13.83% | 16.37B | |
+1.63% | 13.58B | |
+27.96% | 11.66B |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- Transcript : PDS Biotechnology Corporation, Q1 2023 Earnings Call, May 15, 2023